Reviva Pharmaceuticals
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2006-01-01
- Employees
- 15
- Market Cap
- -
- Website
- http://www.revivapharma.com
- Introduction
Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the central nervous system, respiratory, and metabolic diseases. It uses chemical genomics driven technology platform and proprietary chemistry to develop new medicines. It focuses on the RP5063 (Brilaroxazin...
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
- First Posted Date
- 2022-01-11
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- Reviva Pharmaceuticals
- Target Recruit Count
- 690
- Registration Number
- NCT05184335
- Locations
- 🇺🇸
Reviva site, Richardson, Texas, United States
RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-12-12
- Last Posted Date
- 2015-01-26
- Lead Sponsor
- Reviva Pharmaceuticals
- Target Recruit Count
- 234
- Registration Number
- NCT01490086
- Locations
- 🇲🇾
Reviva Site, Ridzuan, Malaysia
🇵🇭Reviva site, Subangdaku, Philippines
© Copyright 2024. All Rights Reserved by MedPath